» Articles » PMID: 8724891

Both IgG- and C1q-receptors Play a Role in the Enhanced Binding of IgG Complexes to Human Mesangial Cells

Overview
Specialty Nephrology
Date 1996 Apr 1
PMID 8724891
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of immunoglobulin G (IgG) in the mesangial area in kidneys of patients with different forms of glomerulonephritis suggests a role for IgG in the inflammatory process. This study investigates whether IgG is able to bind to cultured human mesangial cells (MC) in vitro. Incubation of MC with 125I-aggregated IgG(125I-AIgG), as a model for immune complexes (IC), at 4 degrees C resulted in a time- and dose-dependent binding of 125I-AIgG to MC. The binding of 125I-AIgG to MC was inhibited by excess AIgG or Fc-fragments and not by F(ab')2-fragments or human serum albumin (HSA). Scatchard analysis revealed the presence of 2.8.10(6) receptors/cell with an affinity of 9.7.10(7) M-1. Incubation of MC with 125I-C1q resulted in a time- and dose-dependent binding of 125I-C1q to MC. The binding of 125I-C1q was inhibited by excess C1q or C1q talls and not by HSA. Scatchard analysis revealed the presence of 3.2.10(7) binding sites/cell with an affinity of 1.4.10(7) M-1. Immunoprecipitation of 125I-labeled MC membrane proteins with C1q or monoclonal antibodies directed against human C1q-R revealed a single 66 to 68 kd band under reducing conditions. Fluorescence-activated cell-sorter analysis revealed an average of 60.1% +/- 5.4% of the cells positive with a mean channel of fluorescence of 592. A cooperative effect between C1q-R and Fc gamma-R in the binding of 125I-AIgG to MC, was assessed by incubation of 125I-AIgG in the presence of increasing concentrations of C1q, C1q talls, or delta C1q. Only intact C1q showed a 6- to 11-fold enhancement in binding of 125I-AIgG to MC. These studies demonstrate the occurrence of C1q-R and Fc gamma-R on MC and indicate that binding of IC is enhanced after interaction of IC with C1q.

Citing Articles

[Advances in clinical research on C1q nephropathy].

Yang J, Zhang B Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(11):1194-1198.

PMID: 27817791 PMC: 7389859.


C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?.

Muorah M, Sinha M, Horsfield C, ODonnell P NDT Plus. 2015; 2(4):285-91.

PMID: 25984017 PMC: 4421234. DOI: 10.1093/ndtplus/sfp055.


Update on crescentic glomerulonephritis.

Henique C, Papista C, Guyonnet L, Lenoir O, Tharaux P Semin Immunopathol. 2014; 36(4):479-90.

PMID: 24948005 DOI: 10.1007/s00281-014-0435-7.


Diverse clinical and histology presentation in c1q nephropathy.

Malleshappa P, Vankalakunti M Nephrourol Mon. 2013; 5(3):787-91.

PMID: 24282787 PMC: 3830903. DOI: 10.5812/numonthly.8308.


Differential expression of functional Fc-receptors and additional immune complex receptors on mouse kidney cells.

Suwanichkul A, Wenderfer S Mol Immunol. 2013; 56(4):369-79.

PMID: 23911392 PMC: 3799920. DOI: 10.1016/j.molimm.2013.05.219.